Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104


Bacterial flagellin stimulates Toll-like receptor 5-dependent defense against vancomycin-resistant Enterococcus infection.

Kinnebrew MA, Ubeda C, Zenewicz LA, Smith N, Flavell RA, Pamer EG.

J Infect Dis. 2010 Feb 15;201(4):534-43. doi: 10.1086/650203. Erratum in: J Infect Dis. 2010 Apr 15;201(8):1278.


Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits.

Brandl K, Plitas G, Mihu CN, Ubeda C, Jia T, Fleisher M, Schnabl B, DeMatteo RP, Pamer EG.

Nature. 2008 Oct 9;455(7214):804-7. doi: 10.1038/nature07250. Epub 2008 Aug 24.


TLR-7 activation enhances IL-22-mediated colonization resistance against vancomycin-resistant enterococcus.

Abt MC, Buffie CG, Sušac B, Becattini S, Carter RA, Leiner I, Keith JW, Artis D, Osborne LC, Pamer EG.

Sci Transl Med. 2016 Feb 24;8(327):327ra25. doi: 10.1126/scitranslmed.aad6663.


Interleukin 23 production by intestinal CD103(+)CD11b(+) dendritic cells in response to bacterial flagellin enhances mucosal innate immune defense.

Kinnebrew MA, Buffie CG, Diehl GE, Zenewicz LA, Leiner I, Hohl TM, Flavell RA, Littman DR, Pamer EG.

Immunity. 2012 Feb 24;36(2):276-87. doi: 10.1016/j.immuni.2011.12.011. Epub 2012 Feb 2.


Development of systemic bacteraemia after oral inoculation of vancomycin-resistant enterococci in mice.

Miyazaki S, Fujikawa T, Kobayashi I, Matsumoto T, Tateda K, Yamaguchi K.

J Med Microbiol. 2001 Aug;50(8):695-701.


Toll-like receptor 5 engagement modulates tumor development and growth in a mouse xenograft model of human colon cancer.

Rhee SH, Im E, Pothoulakis C.

Gastroenterology. 2008 Aug;135(2):518-28. doi: 10.1053/j.gastro.2008.04.022. Epub 2008 Apr 23.


TLR5 signaling stimulates the innate production of IL-17 and IL-22 by CD3(neg)CD127+ immune cells in spleen and mucosa.

Van Maele L, Carnoy C, Cayet D, Songhet P, Dumoutier L, Ferrero I, Janot L, Erard F, Bertout J, Leger H, Sebbane F, Benecke A, Renauld JC, Hardt WD, Ryffel B, Sirard JC.

J Immunol. 2010 Jul 15;185(2):1177-85. doi: 10.4049/jimmunol.1000115. Epub 2010 Jun 21.


Innate immune detection of flagellin positively and negatively regulates salmonella infection.

Lai MA, Quarles EK, López-Yglesias AH, Zhao X, Hajjar AM, Smith KD.

PLoS One. 2013 Aug 19;8(8):e72047. doi: 10.1371/journal.pone.0072047. eCollection 2013 Aug 19.


Treatment options for vancomycin-resistant enterococcal infections.

Linden PK.

Drugs. 2002;62(3):425-41. Review.


Toll-like receptor 5 stimulation protects mice from acute Clostridium difficile colitis.

Jarchum I, Liu M, Lipuma L, Pamer EG.

Infect Immun. 2011 Apr;79(4):1498-503. doi: 10.1128/IAI.01196-10. Epub 2011 Jan 18.


Efficacy of oral ramoplanin for inhibition of intestinal colonization by vancomycin-resistant enterococci in mice.

Stiefel U, Pultz NJ, Helfand MS, Donskey CJ.

Antimicrob Agents Chemother. 2004 Jun;48(6):2144-8.


Intestinal microbiota containing Barnesiella species cures vancomycin-resistant Enterococcus faecium colonization.

Ubeda C, Bucci V, Caballero S, Djukovic A, Toussaint NC, Equinda M, Lipuma L, Ling L, Gobourne A, No D, Taur Y, Jenq RR, van den Brink MR, Xavier JB, Pamer EG.

Infect Immun. 2013 Mar;81(3):965-73. doi: 10.1128/IAI.01197-12. Epub 2013 Jan 14.


Both radioresistant and hemopoietic cells promote innate and adaptive immune responses to flagellin.

Sanders CJ, Moore DA 3rd, Williams IR, Gewirtz AT.

J Immunol. 2008 Jun 1;180(11):7184-92. Erratum in: J Immunol. 2008 Aug 15;181(4):2933.


Evaluation of risk factors for vancomycin-resistant Enterococcus bacteremia among previously colonized hematopoietic stem cell transplant patients.

Kang Y, Vicente M, Parsad S, Brielmeier B, Pisano J, Landon E, Pettit NN.

Transpl Infect Dis. 2013 Oct;15(5):466-73. doi: 10.1111/tid.12120. Epub 2013 Aug 4.


Flagellin stimulates protective lung mucosal immunity: role of cathelicidin-related antimicrobial peptide.

Yu FS, Cornicelli MD, Kovach MA, Newstead MW, Zeng X, Kumar A, Gao N, Yoon SG, Gallo RL, Standiford TJ.

J Immunol. 2010 Jul 15;185(2):1142-9. doi: 10.4049/jimmunol.1000509. Epub 2010 Jun 21.


Toll-like receptor 5 is not essential for the promotion of secretory immunoglobulin A antibody responses to flagellated bacteria.

Hashizume-Takizawa T, Yamamoto M.

Microbiol Immunol. 2015 Dec;59(12):716-23. doi: 10.1111/1348-0421.12336.


Unmet needs and prospects for oritavancin in the management of vancomycin-resistant enterococcal infections.

Arias CA, Mendes RE, Stilwell MG, Jones RN, Murray BE.

Clin Infect Dis. 2012 Apr;54 Suppl 3:S233-8. doi: 10.1093/cid/cir924.


Viral infection. Prevention and cure of rotavirus infection via TLR5/NLRC4-mediated production of IL-22 and IL-18.

Zhang B, Chassaing B, Shi Z, Uchiyama R, Zhang Z, Denning TL, Crawford SE, Pruijssers AJ, Iskarpatyoti JA, Estes MK, Dermody TS, Ouyang W, Williams IR, Vijay-Kumar M, Gewirtz AT.

Science. 2014 Nov 14;346(6211):861-5. doi: 10.1126/science.1256999.


Inductive expression of toll-like receptor 5 (TLR5) and associated downstream signaling molecules following ligand exposure and bacterial infection in the Indian major carp, mrigal (Cirrhinus mrigala).

Basu M, Swain B, Maiti NK, Routray P, Samanta M.

Fish Shellfish Immunol. 2012 Jan;32(1):121-31. doi: 10.1016/j.fsi.2011.10.031. Epub 2011 Nov 7.


A Toll-Like Receptor 5 Agonist Improves the Efficacy of Antibiotics in Treatment of Primary and Influenza Virus-Associated Pneumococcal Mouse Infections.

Porte R, Fougeron D, Muñoz-Wolf N, Tabareau J, Georgel AF, Wallet F, Paget C, Trottein F, Chabalgoity JA, Carnoy C, Sirard JC.

Antimicrob Agents Chemother. 2015 Oct;59(10):6064-72. doi: 10.1128/AAC.01210-15. Epub 2015 Jul 20.

Supplemental Content

Support Center